Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bodisen Biotech Announces Completion of New Manufacturing Facility and Sees Record 2005 Earnings.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- Bodisen Biotech bi·o·tech  
n. Informal
Biotechnology.


biotech
Noun

short for biotechnology

Noun 1.
, Inc., (stock symbol: BBOI, website: www.bodisen.com) announced today that it has completed the construction of its new 609,840 square foot manufacturing facility. The new facility will double the annual production of Bodisen's organic fertilizer from 100,000 metric tons to 200,000 metric tons.

Ms. Qiong Wang, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Bodisen, commented, "Although we will report record earnings for year 2004, we were unable to completely satisfy overwhelming customer demand for Bodisen branded products because of our production capacity of 100,000 metric tons. We are very pleased that our new manufacturing facility will double last year's production output to 200,000 metric tons, which will enable us to meet growing customer demand for our products. We have also ordered an additional three sets of new production lines, which will further expand our production capabilities."

Ms. Wang continued with her comments on the market environment: "One of the major milestones in the Chinese agricultural industry in the last few decades took place in recent months, which is the Chinese government's initiation of pro-farmer policies that have given farmers both long term ownership rights as well as increased disposable income disposable income

Portion of an individual's income over which the recipient has complete discretion. To assess disposable income, it is necessary to determine total income, including not only wages and salaries, interest and dividend payments, and business profits, but also
 to spend on fertilizers. As a result, we are seeing a very favorable market environment for our products as farmers are able to put more financial resources to the enrichment of soil in their fields. As we continue to expand our products lines as well as marketing efforts, we foresee record 2005 sales and earnings."

About Bodisen Biotech, Inc.

Bodisen is a leader in the manufacturing and marketing of "green" organic fertilizers in China. The company is located in the heart of Shaanxi Province, the gateway to the vast western regions of China. Its broad selection of 60 products includes solid and liquid fertilizers, as well as pesticides and insecticides insecticides, chemical, biological, or other agents used to destroy insect pests; the term commonly refers to chemical agents only. Chemical Insecticides
, which address a variety of grain and vegetable crops.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Statement

This press release may contain forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. These statements are based on the current expectations or beliefs of Bodisen Biotech, Inc. management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 15, 2005
Words:381
Previous Article:Odyssey Pharmaceuticals and Indevus Pharmaceuticals Announce Odyssey's Plans to Initiate Phase IV Open Label Study of the Effectiveness and Safety of...
Next Article:Growth of Multi-Process Human Resources Outsourcing Grew by 37 Percent in 2004, According to Everest Research Institute Report.



Related Articles
Bodisen Hosts Institutional Road Show in China and Sees Record 3rd Quarter Earnings.
GPC BIOTECH/DEBIOPHARM SIGN MHC II ANTAGONISTS LICENSE PACT.
Bodisen Biotech Received Contracts Totaling $27.4 Million in January for 2005 Product Delivery.
Bodisen Biotech Reports Earnings Per Share of $0.33 for 2004 and a 155% Increase in Net Income.
The SEC Declared Effective Bodisen Biotech's Recent SB-2 Registration Statement and Bodisen Successfully Hosts Global Fund Managers in Yang Ling.
Bodisen Biotech Announces Record Second Quarter Earnings of $0.17 per Share, 99% Increase in Revenue and 48% Increase in Net Income; Bodisen Provides...
Acquisition of pharmaceutical information group by Wolters Kluwer Health.
Bodisen Biotech Announces 3rd Quarter Earnings of $0.22 per Share, 94% Increase in Revenue and 80% Increase in Net Income; Before a One Time...
Bodisen Biotech Sees Record 1st Quarter Net Income, Company Provides Guidance for Accelerated Sales and Earnings Growth in 2006.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles